Last reviewed · How we verify

Axillary block anesthesia with Ropivacaine and Lidocaine

Hospices Civils de Lyon · Phase 1 active Small molecule Quality 0/100

Axillary block anesthesia with Ropivacaine and Lidocaine is a Small molecule drug developed by Hospices Civils de Lyon. It is currently in Phase 1 development.

At a glance

Generic nameAxillary block anesthesia with Ropivacaine and Lidocaine
SponsorHospices Civils de Lyon
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Axillary block anesthesia with Ropivacaine and Lidocaine

What is Axillary block anesthesia with Ropivacaine and Lidocaine?

Axillary block anesthesia with Ropivacaine and Lidocaine is a Small molecule drug developed by Hospices Civils de Lyon.

Who makes Axillary block anesthesia with Ropivacaine and Lidocaine?

Axillary block anesthesia with Ropivacaine and Lidocaine is developed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).

What development phase is Axillary block anesthesia with Ropivacaine and Lidocaine in?

Axillary block anesthesia with Ropivacaine and Lidocaine is in Phase 1.

Related